Reviews and Information for Royal
Filters
View All
Search term may appear only in full report available to members. Join now for full access.
Product Review
Ginseng Supplements Review
Find the Best Ginseng Supplement. Key "Ginsenosides" Found to Range 10-Fold Across Products.
CL Answer
Do any supplements help reduce menstrual pain or symptoms of premenstrual syndrome (PMS)?
Find out which supplements help reduce premenstrual syndrome (PMS) symptoms, such as mood swings, pain, bloating, irritability and food cravings.
Recalls & Warnings
July 13, 2022
FDA Warns Sellers of Tainted Honey-Based Sexual Enhancement Products
On July 12, 2022, the FDA issued warning letters to four companies selling honey-based products promoted for sexual enhancement after tests conducted by the FDA found the products to contain the prescription drugs Tadalafil and Sildenafil.
Product Review
Echinacea Supplements Review
Many Echinacea Supplements Fail CL's Tests. Make Sure You Know What You're Getting!
Recalls & Warnings
July 15, 2022
Honey-Based Enhancement Supplement Recalled
On July 13, 2022, Shopaax.com issued a recall of all lots of its honey-based sexual enhancement product, Kingdom Honey Royal Honey VIP, after FDA analysis found the presence of undeclared sildenafil.
Recalls & Warnings
June 19, 2013
Sexual Enhancement Supplement Found To Contain Undeclared Drug
On June 17, 2013, the FDA advised consumers not to purchase or use sexual enhancement supplement Royal Dragon Herbal Tonic Balls because it was found to contain undeclared vardenafil.
Recalls & Warnings
November 18, 2003
Supplement Promoted As Cancer Treatment Removed from Market
On November 10, 2003, the Food and Drug Administration (FDA) announced that NBTY, Inc., of Bohemia, N.Y.
Recalls & Warnings
March 16, 2023
Omega-3 Supplements for Dogs and Cats Recalled Due to Potential for Vitamin A Toxicity
On March 9, 2023, Stratford Care USA issued a recall of 62 brands of omega-3 supplements for dogs and cats due to potentially elevated levels of vitamin A.
Recalls & Warnings
October 12, 2005
Supplement Company to Pay $2 Million Penalty For Alleged Violations of FTC Order
On October 12, 2005 the Federal Trade Commission (FTC) announced that under the terms of a consent decree approved by the it for submission by the U.S. Department of Justice (DOJ) to the federal court for approval, NBTY, Inc. (NBTY, formerly Nature’s Bounty, Inc.
Recalls & Warnings
May 09, 2020
FTC Warns 45 More Companies for Coronavirus Claims
On May 7, 2020, the FTC announced that it sent warning letters to 45 companies for selling products such as herbal products, immune system boosters, and vitamin C with unsupported claims that they can treat coronavirus (COVID-19).
Recalls & Warnings
December 19, 2020
FDA Finds Unapproved Drugs in Many Weight Loss and Sexual Enhancement Products Sold Online
On December 18, 2020, the FDA warned consumers that certain products promoted for weight loss, body building, sexual enhancement, pain relief, sleep, and other uses because may contain harmful ingredients.
Recalls & Warnings
July 18, 2017
Hidden Drugs Found in Sexual Enhancement Products
On July 17, 2017, the FDA posted public notifications after finding multiple sexual enhancement products contained hidden drug ingredients.
Recalls & Warnings
March 08, 2012
Supplement Maker Warned About Cancer Claims
FDA issued a letter to Royal Domains (dated January 6, 2012) warning that their Nature's Pearl Premium Muscadine Grape Seed dietary supplement is being promoted as a drug and as such is misbranded.
Recalls & Warnings
March 19, 2009
QVC Settles Charges of False Claims for Supplements
On March 19, 2009, the Federal Trade Commission (FTC) announced that QVC, Inc., a TV home shopping channel and one of the world’s largest multimedia retailers, has agreed to pay $7.
Recalls & Warnings
September 17, 2013
Seller of Omega-3 and Joint Supplements Warned for Manufacturing Violations and Drug Claims
On August 29, 2013, the FDA issued a warning letter to Y.S. Health Corp.
Recalls & Warnings
June 22, 2017
FDA Finds Hidden Drug Ingredients in Sexual Enhancement Supplements
On June 22, 2017, the FDA warned consumers that the following sexual enhancement supplements were found to contain undeclared sildenafil, tadalafil and/or dapoxetine. Use the links below to read the complete warning letter for each:
- Triple Premium Zen Gold 1300 mg
Recalls & Warnings
March 11, 2003
Rexall Agrees to Pay up to $12 million to Users of Misleading Cellulite Supplement
On March 11, 2003, the Federal Trade Commission (FTC) reported that Rexall Sundown, Inc. (Rexall) will pay up to $12 million to resolve FTC charges regarding its marketing of the dietary supplement, "Cellasene," a purported cellulite treatment product.
Recalls & Warnings
May 30, 2015
Seller of Omega-3, Probiotics & SuperFoods Warned for Manufacturing Violations, Drug Claims
On May 4, 2015, the FDA issued a warning letter to Dr. Dennis Black, LLC.
Recalls & Warnings
April 04, 2013
Three More Sexual Enhancement Supplements Found To Contain Undeclared Drugs
On April 3, 2013, the FDA warned consumers that the sexual enhancement supplements AFFIRM XL, Love Rider and Ninja Mojo were found to contain undeclared erectile dysfunction drugs. Consumers are urged to stop using these supplements immediately.
Recalls & Warnings
June 23, 2017
FDA Warns Seller of Menopause, Sexual Enhancement, Prostate Supplements and More For Manufacturing Violations
On May 26, 2017 the FDA issued a warning letter to Star Health & Beauty LLC, following a facility inspection which found the company's products, including Nu Essentials Royal Jelly Capsules, NuMan Male Enhancement Capsules, Star's Male Potency Tonic, NuGen HP, She Max HP, and V Max ...
Recalls & Warnings
November 06, 2014
Seller of Cholesterol, Arthritis Supplements and More Warned for Drug Claims
On October 17, 2014, the FDA issued a warning letter to Vitamins Direct (USA) and Golden Pride, Inc., which distribute Flexezy and Physician's Signature brands of dietary supplements, following a facility inspection which found statements made about certain supplements to be drug claims.
Recalls & Warnings
March 13, 2020
FDA Finds Problems at 52% of Supplement Manufacturing Sites in U.S. and 42% Abroad
ConsumerLab.com has obtained results of the FDA's inspections in Fiscal Year 2019 (October 1, 2018 - September 30, 2019) of 598 dietary supplement manufacturing facilities in the U.S.
